The Impact of Inherited Retinal Diseases in the United States of America (US) and Canada from a Cost-of-Illness Perspective

References

• Duncan JL, Pierce EA, Laster AM, et al. Foundation Fighting Blindness Scientific Advisory Board. Inherited retinal degenerations: current landscape and knowledge gaps. Trans Vis Sci Tech. 2018;7(4):1–15. doi:10.1167/tvst.7.4.6
   Web of Science ®Google Scholar
• Hafler BP. Clinical progress in inherited retinal degenerations: gene therapy clinical trials and advances in genetic sequencing. Retina. 2017;37(3):417–423. doi:10.1097/IAE.0000000000001341
   PubMed Web of Science ®Google Scholar
• Sergouniotis PI. Inherited Retinal Disorders: using Evidence as a Driver for Implementation. Ophthalmologica. 2019;242(4):187–194. doi:10.1159/000500574
   Web of Science ®Google Scholar
• National Center for Advancing Translational Sciences. Rare Diseases are not Rare!; 2019. Available from: https://ncats.nih.gov/director/feb-2019. Accessed August 24, 2020.
   Google Scholar
• Canadian Agency for Drugs and Technologies in Health (CADTH). The impact of inherited retinal diseases on Canadian patients: patient input on Luxturna; 2020. Available from: https://cadth.ca/sites/default/files/cdr/relatedinfo/Luxturna%20-%20Patient%20Group%20Input_For%20Posting.pdf. Accessed August 24, 2020.
   Google Scholar
• Canadian Agency for Drugs and Technologies in Health (CADTH). Voretigene Neparvove, 2021. Available from: https://cadth.ca/voretigene-neparvovec. 10, 2021.
   Google Scholar
• Mayro EL, Murchison AP, Hark LA, et al. Prevalence of depressive symptoms and associated factors in an urban, ophthalmic population. Eur J Ophthalmol. 2020;1–8.
   Web of Science ®Google Scholar
• Zhang X, Bullard KM, Cotch MF, et al. Association between depression and functional vision loss in persons 20 years of age or older in the United States, NHANES 2005-2008. JAMA Ophthalmol. 2013;131(5):573–581. doi:10.1001/jamaophthalmol.2013.2597
   PubMed Web of Science ®Google Scholar
• DeCarlo D, McGwin G, Bixler ML, et al. Impact of Pediatric Vision Impairment on Daily Life: results of Focus Groups. Optom Vis Sci. 2013;89(9):1409–1416. doi:10.1097/OPX.0b013e318264f1dc
   Web of Science ®Google Scholar
• Deloitte Access Economics. The socioeconomic impact of inherited retinal dystrophies (IRDs) in the United States of America. 2020. Available from: https://www2.deloitte.com/au/en/pages/economics/articles/socioeconomic-impact-inherited-retinal-dystrophies-us-canada.html. Accessed March 10, 2021.
   Google Scholar
• Deloitte Access Economics. The socioeconomic impact of inherited retinal dystrophies (IRDs) in Canada. 2020. Available from: https://www2.deloitte.com/au/en/pages/economics/articles/socioeconomic-impact-inherited-retinal-dystrophies-us-canada.html. Accessed March 10, 2021.
   Google Scholar
• Ridic G, Gleason S, Ridic O. Comparisons of Health Care Systems in the United States, Germany and Canada. Mater Sociomed. 2012;24(2):112–120. doi:10.5455/msm.2012.24.112-120
   PubMedGoogle Scholar
• Government of Canada. Canada’s Health Care System. 2019. Available from: https://www.canada.ca/en/health-canada/services/health-caresystem/reports-publications/health-care-system/canada.html. Accessed August 19, 2020.
   Google Scholar
• Cruess AF, Gordon KD, Bellan L, et al. The cost of vision loss in Canada. 2. Results. Can J Ophthalmol. 2011;56(4):218–315. doi:10.1016/j.jcjo.2011.06.006
   Web of Science ®Google Scholar
• Canadian National Institute of the Blind. 2021. Available from: https://cnibsmartlife.ca/. Accessed January 27, 2021.
   Google Scholar
• AHRQ. Agency for Healthcare Research and Quality Healthcare Cost and Utilization Project (HCUP); 2019. Available from: https://www.ahrq.gov/data/hcup/index.html. Accessed August 27, 2020.
   Google Scholar
• Centers for Medicare & Medicaid Services (CMS). National Health Expenditure Data; 2019. Available from: https://www.cms.gov/Research-StatisticsData-and-Systems/Statistics-Trends-andReports/NationalHealthExpendData. 27, 2020.
   Google Scholar
• Vision Loss in Canada. 2011. Available from: https://www.cos-sco.ca/wp-content/uploads/2012/09/VisionLossinCanada_e.pdf. Accessed August 22, 2020.
   Google Scholar
• GBD. 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1789–1858. doi:10.1016/S0140-6736(18)32279-7
   PubMed Web of Science ®Google Scholar
• Dahlby B, Ferede E The Marginal Cost of Raising Tax Revenue: implications for Tax Policy Options in Alberta. 2011. Available from: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=1805108. Accessed August 19, 2020.
   Google Scholar
• Blomquist S, Simula L Marginal deadweight loss when the income tax is nonlinear. CESifo Working Paper No. 3053. 2010;211:47–60.
   Google Scholar
• Fullerton D, Ta CL. Public Finance in a Nutshell: a Cobb Douglas Teaching Tool for General Equilibrium Tax Incidence and Excess Burden (No. w23064). Natl Bureau Econ Res. 2017.
   Google Scholar
• Saez E, Slemrod J, Giertz SH. The elasticity of taxable income with respect to marginal tax rates: a critical review. J Econ Lit. 2012;50(1):3–50. doi:10.1257/jel.50.1.3
   Web of Science ®Google Scholar
• Baicker K, Skinner J. Health care spending growth and the future of US tax rates. Natl Bur Econ Res Bull Aging Health. 2011;25(1):39–68.
   Google Scholar
• Ontario Health. Assistive Devices Program. 2021. Available from: https://www.ontario.ca/page/assistive-devices-program. Accessed January 25, 2021.
   Google Scholar
• Canadian Guide Dogs for the Blind; 2021. Available from: https://www.guidedogs.ca/. Accessed June 18, 2021. 25, 2021.
   Google Scholar
• Daiger SP, Sullivan LS, Bowne SJ. Genes and mutations causing retinitis pigmentosa. Clin Genet. 2013;84(2):132–141. doi:10.1111/cge.12203
   PubMed Web of Science ®Google Scholar
• National Institute of Neurological Disorders and Stroke. Focus on Parkinson’s Disease Research; 2021. Available from: https://www.ninds.nih.gov/Current-Research/Focus-Disorders/Parkinsons-Disease#:~:text=At%20the%20National%20Institutes%20of,in%20NIH%2Dsupported%20PD%20research. Accessed January 27, 2021.
   Google Scholar
• National Institute of Health. Research Portfolio Online Reporting Tools. 2020. Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC). Available from: https://report.nih.gov/funding/categorical-spending#/. Accessed January 27, 2021.
   Google Scholar
• Canadian Arthritis Network. Canadian Arthritis Funding Landscape Review. Available from: https://www.arthrite.ca/AS/media/pdf/Researchers/Arthritis-Funding-Final-Final-Landscape-Review.pdf. Accessed March 10, 2021.
   Google Scholar
• Statistics Canada. Arthritis; 2016. Available from: https://www150.statcan.gc.ca/n1/pub/82-229-x/2009001/status/art-eng.htm. Accessed March 10, 2021.
   Google Scholar
• Petty RE, Southwood TR, Manners P, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31(2):390–392.
   PubMed Web of Science ®Google Scholar
• Ens A, Lang B, Ramsey S, et al. The financial burden of juvenile idiopathic arthritis: a Nova Scotia experience. Pediatr Rheumatol Online J. 2013;11(1):24. doi:10.1186/1546-0096-11-24
   PubMed Web of Science ®Google Scholar
• Davis K, Schoenbaum SC, Audet AMA. 2020 vision of patient-centered primary care. J Gen Intern Med. 2005;20(10):953–957. doi:10.1111/j.1525-1497.2005.0178.x
   PubMed Web of Science ®Google Scholar
• Gordon KD The Impact of the COVID-19 Pandemic on Canadians who are Blind, Deaf-Blind and Partially-Sighted; 2020. Available from: https://ccbnational.net/shaggy/2020/05/05/covid-19-survey-results/. Accessed March 10, 2021.
   Google Scholar